Structural Biology and Protein Engineering of Thrombolytics

Myocardial infarction and ischemic stroke are the most frequent causes of death or disability worldwide. Due to their ability to dissolve blood clots, the thrombolytics are frequently used for their treatment. Improving the effectiveness of thrombolytics for clinical uses is of great interest. The k...

Descripción completa

Detalles Bibliográficos
Autores principales: Mican, Jan, Toul, Martin, Bednar, David, Damborsky, Jiri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637190/
https://www.ncbi.nlm.nih.gov/pubmed/31360331
http://dx.doi.org/10.1016/j.csbj.2019.06.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637190/
https://www.ncbi.nlm.nih.gov/pubmed/31360331
http://dx.doi.org/10.1016/j.csbj.2019.06.023

Ejemplares similares